Business Description
Bio-Techne Corp
NAICS : 325414
SIC : 2836
ISIN : US09073M1045
Total Employee Number:
3,100Description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.72 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 1.13 | |||||
Interest Coverage | 30.39 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 15.83 | |||||
Beneish M-Score | -2.55 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.3 | |||||
3-Year EBITDA Growth Rate | -18.6 | |||||
3-Year EPS without NRI Growth Rate | -0.9 | |||||
3-Year FCF Growth Rate | -2 | |||||
3-Year Book Growth Rate | 4.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 6.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.37 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -54.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.49 | |||||
Quick Ratio | 3.18 | |||||
Cash Ratio | 1.37 | |||||
Days Inventory | 170.38 | |||||
Days Sales Outstanding | 61.92 | |||||
Days Payable | 23.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.12 | |||||
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | 1.71 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.96 | |||||
Operating Margin % | 24.31 | |||||
Net Margin % | 9.05 | |||||
EBITDA Margin % | 21.24 | |||||
FCF Margin % | 22.28 | |||||
OCF Margin % | 24.35 | |||||
ROE % | 5.48 | |||||
ROA % | 4.28 | |||||
ROIC % | 9.58 | |||||
3-Year ROIIC % | -22.24 | |||||
ROC (Joel Greenblatt) % | 24.53 | |||||
ROCE % | 6.52 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 102.93 | |||||
Forward PE Ratio | 30.54 | |||||
PE Ratio without NRI | 36.61 | |||||
Shiller PE Ratio | 58.91 | |||||
Price-to-Owner-Earnings | 86.29 | |||||
PS Ratio | 9.2 | |||||
PB Ratio | 5.33 | |||||
Price-to-Tangible-Book | 14.09 | |||||
Price-to-Free-Cash-Flow | 41.36 | |||||
Price-to-Operating-Cash-Flow | 37.82 | |||||
EV-to-EBIT | 71.07 | |||||
EV-to-Forward-EBIT | 28.14 | |||||
EV-to-EBITDA | 43.34 | |||||
EV-to-Forward-EBITDA | 26.78 | |||||
EV-to-Revenue | 9.21 | |||||
EV-to-Forward-Revenue | 9.14 | |||||
EV-to-FCF | 41.34 | |||||
Price-to-GF-Value | 0.98 | |||||
Price-to-Projected-FCF | 2.78 | |||||
Price-to-Median-PS-Value | 0.88 | |||||
Price-to-Graham-Number | 4.79 | |||||
| Price-to-Net-Current-Asset-Value | 50.02 | |||||
Earnings Yield (Greenblatt) % | 1.41 | |||||
FCF Yield % | 2.44 | |||||
Forward Rate of Return (Yacktman) % | -3.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio-Techne Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 22,204.55 | ||
| EPS (TTM) (MXN) | 12.366 | ||
| Beta | -0.0622 | ||
| 3-Year Sharpe Ratio | -0.87 | ||
| 3-Year Sortino Ratio | -0.86 | ||
| Volatility % | 54.9 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (MXN) | 0.000431 | ||
| 20-Day SMA (MXN) | 1090 | ||
| 12-1 Month Momentum % | -54.94 | ||
| 52-Week Range (MXN) | 1090 - 2418.75 | ||
| Shares Outstanding (Mil) | 155.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio-Techne Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio-Techne Corp Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| First quarter earnings conference call for 2027 | 2026-11-05 08:00 | In 130 days | ||
| First quarter earnings results for 2027 | 2026-11-05 | In 129 days | ||
| General meeting for 2026 | 2026-10-30 08:00 | In 124 days | ||
| Annual report for 2026 | 2026-08-21 | In 53 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-08-06 08:00 | In 39 days | ||
| Fourth quarter earnings results for 2026 | 2026-08-06 | In 38 days | ||
| USD 0.080000 Cash Dividend | 2026-05-18 | 1,090.00 (+0.00%) | ||
| Guidance call for 2026 | 2026-05-12 09:20 | 1,090.00 (+0.00%) | ||
| Third quarter earnings conference call for 2026 | 2026-05-06 08:00 | 1,090.00 (+0.00%) | ||
| Third quarter earnings results for 2026 | 2026-05-06 | 1,090.00 (+0.00%) |
Show
Entries
Bio-Techne Corp Frequently Asked Questions
What is Bio-Techne Corp(MEX:TECH)'s stock price today?
The current price of MEX:TECH is MXN1090.00. The 52 week high of MEX:TECH is MXN2418.75 and 52 week low is MXN1090.00.
When is next earnings date of Bio-Techne Corp(MEX:TECH)?
The next earnings date of Bio-Techne Corp(MEX:TECH) is 2026-08-06 Est..
Does Bio-Techne Corp(MEX:TECH) pay dividends? If so, how much?
Bio-Techne Corp(MEX:TECH) does not pay dividend.
Press Release
Articles on Bio-Techne Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers